A company overview connecting Raysun’s development, manufacturing and technical capabilities across peptide, oligonucleotide and sterile drug-product programs.
Raysun supports pharmaceutical programs through an integrated, project-led model that brings together scientific, process, analytical, quality and manufacturing perspectives. Each collaboration begins with a review of the product, development stage and intended outcome.
The platform is positioned to support qualified work involving peptide APIs, oligonucleotides and sterile drug products. Available activities and responsibilities vary by program and are confirmed after technical, quality and business review.
This company feature introduces the connections between development and manufacturing teams and shows how clients can begin a focused discussion about their next milestone.